SCHEMBL9750804

SCHEMBL9750804

O=C1[C@@H]2CCC=C[C@@H]2C1(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9750824 1.00
SCHEMBL9750876 1.00
SCHEMBL10384769 0.81 CYP19A1 (0.31)
SCHEMBL9793824 0.81 CYP19A1 (0.31)
SCHEMBL10384721 0.81 CYP19A1 (0.31)
SCHEMBL4739025 0.79
SCHEMBL9793937 0.77 ALDH1A1 (0.31)
SCHEMBL9750823 0.76
SCHEMBL9750992 0.76
SCHEMBL9809814 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0257610-A2 Process and intermediates for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives and for the synthesis of bicyclo(4.2.0)octane derivatives SYNTEX (U.S.A.) INC. (US) 1988-03-02 EP claimed
US-5049497-A Novel process for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives SYNTEX (U.S.A.) INC. (US) 1991-09-17 US disclosed
US-4927963-A Novel processes for the synthesis of certain bicyclo(4.2.0)octane derivatives with valuable therapeutic properties SYNTEX (U.S.A.) INC. (US) 1990-05-22 US disclosed
US-4735966-A ANTICOAGULANTS, VASODILATORS, HYPOTENSIVE AND ANTICHOLESTEROL AGENTS SYNTEX (U.S.A.) INC. (US) 1988-04-05 US disclosed
EP-0257610-A2 Process and intermediates for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives and for the synthesis of bicyclo(4.2.0)octane derivatives SYNTEX (U.S.A.) INC. (US) 1988-03-02 EP disclosed
EP-0257609-A2 Novel substituted (4.2.0)Bicyclooctane derivatives with valuable therapeutic properties SYNTEX (U.S.A.) INC. (US) 1988-03-02 EP disclosed